Company Filing History:
Years Active: 2020-2023
Title: Innovations in Cell Culture Technology by Inventor Lisa Pieper
Introduction
Lisa Pieper, an accomplished inventor based in Biberach an der Riss, Germany, has made significant contributions to the field of cell culture technology. With a total of two patents to her name, her work focuses on improving the production of biopharmaceuticals through innovative approaches in mammalian cell lines.
Latest Patents
Lisa Pieper's most notable patents revolve around the enhancement of mammalian cells for producing secreted proteins. Her recent invention details the process of knockdown using RNA interference or gene knockout techniques targeting the activating transcription factor 6 beta (ATF6B). Additionally, her work explores the combination of ceramide synthase 2 (CERS2) and TBC1 domain family member 20 (TBC1D20) proteins. The downregulation of these factors leads to improved secretion of biopharmaceutically relevant products from mammalian cells. This innovation specifically addresses enhanced secretion of recombinant therapeutic proteins and offers methods for producing these mammalian cells to increase yields significantly.
Career Highlights
Lisa currently works at Boehringer Ingelheim International GmbH, a leading company in the healthcare and biopharmaceutical sectors. Her collaboration with esteemed colleagues such as Monilola Olayioye and Angelika Hausser further emphasizes the dynamic environment of research and innovation within her organization.
Collaborations
Throughout her career, Lisa has engaged with various professionals in her field, strengthening her work and contributing to groundbreaking advancements in cell culture technology. Collaborating with experts like Monilola Olayioye and Angelika Hausser has allowed her to refine her ideas and enhance the impact of her inventions on biopharmaceutical production processes.
Conclusion
Lisa Pieper stands out as a prominent figure in the field of cell culture technology, continuously pushing the boundaries of scientific innovation. Her recent patents demonstrate a commitment to improving recombinant therapeutic protein production, offering promising solutions for the biopharmaceutical industry. Through her work at Boehringer Ingelheim International GmbH and her collaboration with talented coworkers, Lisa's contributions are set to shape the future of biotechnology significantly.